Global Cord Blood Corp (CORBF)
OTCMKTS: CORBF · Delayed Price · USD
1.350
0.00 (0.00%)
Mar 28, 2024, 1:55 PM EDT - Market closed
Global Cord Blood Market Cap
Global Cord Blood has a market cap or net worth of $180.79 million as of March 28, 2024. Its market cap has decreased by -67.53% in one year.
Market Cap
180.79M
Enterprise Value
-740.82M
1-Year Change
-67.53%
Ranking
n/a
Category
Stock Price
$1.35
Market Cap Chart
Since May 14, 2007, Global Cord Blood's market cap has decreased from $663.70M to $180.79M, a decrease of -72.76%. That is a compound annual growth rate of -8.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2022 | 363.20M | - |
Sep 23, 2022 | 363.20M | 34.62% |
Sep 22, 2022 | 269.80M | -3.51% |
Sep 21, 2022 | 279.60M | -2.95% |
Sep 20, 2022 | 288.10M | -2.07% |
Sep 19, 2022 | 294.20M | -0.41% |
Sep 16, 2022 | 295.40M | -4.31% |
Sep 15, 2022 | 308.70M | 4.93% |
Sep 14, 2022 | 294.20M | 3.88% |
Sep 13, 2022 | 283.20M | 1.29% |
Sep 12, 2022 | 279.60M | 3.63% |
Sep 9, 2022 | 269.80M | - |
Sep 8, 2022 | 269.80M | 0.45% |
Sep 7, 2022 | 268.60M | -1.79% |
Sep 6, 2022 | 273.50M | -2.60% |
Sep 2, 2022 | 280.80M | -0.43% |
Sep 1, 2022 | 282.00M | 0.43% |
Aug 31, 2022 | 280.80M | 5.96% |
Aug 30, 2022 | 265.00M | 0.91% |
Aug 29, 2022 | 262.60M | -6.08% |
Aug 26, 2022 | 279.60M | 3.63% |
Aug 25, 2022 | 269.80M | -6.74% |
Aug 24, 2022 | 289.30M | -0.82% |
Aug 23, 2022 | 291.70M | 1.67% |
Aug 22, 2022 | 286.90M | 0.88% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 735.08B |
Novo Nordisk | 580.33B |
UnitedHealth Group | 450.93B |
Johnson & Johnson | 374.05B |
Merck & Co. | 317.37B |
AbbVie | 317.35B |
Thermo Fisher | 218.71B |
AstraZeneca | 207.09B |